MLA Dec15 Quarterly projection

Looking ahead to upcoming trading updates, I thought I’d take a guess at where MLAs results might be in a month or so.

29th Jan - Dec15 Quarterly update's due.

My Estimate: Dec15 Q 4.21m (Prev: Dec14 Q, 3.8m)
Up 10.80% (based on Tuta/Clements Sales growth of approx. 15%, roughly in line with previous quarter's growth) I believe there is potential for a flat to small positive Quarter’s cashflow - dependent on costs associated with the sale of Medivet. I’m thinking we shouldn’t see too much of a drop back in this Quarterly's Revenue as Medivet’s ‘contribution’ will still be reported under the Dec Quarter’s results.


26^th Feb: - Half Year update/ Commentary due.

My Expectations:
- Upbeat sales predictions with possibly a further appointment of sales staff to capitalize on ongoing growth, (expecting FY revenue projections to be flat with growth in Human/OEM business offseting half a year's worth of lost Medivet revenue)
- An update on the progression of Medivet sale (ie $2million), outline of plan for reinvestment if $2million is realised (working capital, 'searching for acquisitions' etc)
- Projection of a small breakeven FY profit.


Share Price in February:
I’d see the SP sitting around these levels (6.2c) until at least the next quarterly. The market will need to see some follow through from MLA management before any significant appreciation takes place. With the Medivet sale out of the way I wonder whether Ellis and co, would view the 8mill market cap (and "potential" 1mill npat) as a value level and consider dipping into their own pockets? Nice juicy 500k parcel sitting at 6.7c…?

Happy New Year to all, & DYOR, IMO etc…